Biostage, Inc. (NASDAQ: BSTG) is pioneering radically new technologies for the development of bioengineered organ implants targeting cancer and other life-threatening diseases of the esophagus, bronchus, and trachea. Traditional treatment options for such diseases are limited, with significant risk of complications and negative effect on quality of life. The company’s Cellframe™ technology uses the patient’s […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.